NCT03829150View on ClinicalTrials.gov

Dexlansoprazole MR-Based Concomitant Quadruple Therapy

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

April 20, 2019

Study Completion Date

April 20, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Dexlan

Dexlansoprazole MR 60 mg qd for 7 days

DRUG

Amoxicillin

Amoxicillin (Amolin) 1 g bid. for 7 days

DRUG

Clarithromycin 500mg

clarithromycin (Klaricid) 500 mg bid for 7 days

DRUG

Metronidazole

Metronidazole (Flagyl) 500 mg bid daily for 7 days

Trial Locations (1)

833

Kaohsiung Chang Gung Memorial Hospital,Taiwan, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT03829150 - Dexlansoprazole MR-Based Concomitant Quadruple Therapy | Biotech Hunter | Biotech Hunter